ArticleJournal of inflammation research2024
Development of a Prognostic Nomogram for Nonneutropenic Invasive Pulmonary Aspergillosis Based on Machine Learning.
Article in Journal of inflammation research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Predicting Mortality in Intensive Care Unit Patients With Allergic Bronchopulmonary Aspergillosis (ABPA) Using an Interpretable Machine Learning Model: A Retrospective Cohort Study.Canadian respiratory journal · 2026Article
- Relational needs satisfaction scale: adaptation to the Bosnian language and psychometric testing.Frontiers in psychology · 2025Article
- Epidemiological shifts and advances in research on early diagnosis of invasive fungal infection in critically ill patients.Frontiers in cellular and infection microbiology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The incidence of invasive pulmonary aspergillosis (IPA) is progressively rising in the nonneutropenic population, but studies investigating relevant prognostic factors remain scarce. Methods: Participants who were hospitalized at Zhongshan City People's Hospital from January 2018 to May 2023 and diagnosed with nonneutropenic deficient IPA were included in this study. The least absolute shrinkage and selection operator (LASSO) regression and multivariate Cox regression methods were used to select variables for constructing the predictive model. The performance of the predictive model was evaluated using the concordance index (C-index), calibration curve, time-dependent receiver operating characteristic (T-ROC) curve, area under the curve (AUC), and decision curve analysis (DCA). Finally, prognostic risk stratification was performed for nonneutropenic IPA patients, transforming the nomogram into a risk-stratified prognostic model. Results: A total of 210 participants were included in this study, divided into training and validation cohorts at a ratio of 7.5:2.5. Lasso regression identified seven potential predictive factors, including age, comorbid bacterial pneumonia, pleural effusion, neutrophil to lymphocyte ratio (NLR), lactate dehydrogenase (LDH), invasive mechanical ventilation and ICU treatment. Multivariate Cox regression analysis showed age (HR=1.02), comorbid bacterial pneumonia (HR=3.36), NLR (HR=1.02), LDH (HR=1.001), and invasive mechanical ventilation (HR=4.86) as independent predictive factors and constructed nomogram. The calibration curves show that the nomogram performs well in terms of consistency between predictions and actual observations. The T-ROC curves and DCA of the nomogram model show that the recognition ability of the nomogram model was outstanding. Participants could be classified into high and low-risk groups based on the final score of this nomogram, demonstrating the excellent risk stratification performance of our model. Conclusion: The nomogram model developed in this study is an effective tool for predicting mortality risk in nonneutropenic IPA patients, aiding clinicians in identifying high-risk patients and optimizing early treatment strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.